Organophosphorus compounds (organophosphates and organophosphonates) exert their toxicity by phosphylating (i.e. either phosphorylating or phosphonylating) the serine hydroxyl group of the enzyme acetylcholinesterase (AChE) in its active center, thereby inhibiting this enzyme, which inactivates the neurotransmitter acetylcholine (ACh). This results in an accumulation of ACh and an "endogenous ACh poisoning".
INTRODUCTION
Organophosphorus esters (organophosphates and organophosphonates) which are used as pesticides and parasiticides are amongst the most frequent causes of accidental and suicidal intoxications [1] [2] [3] . Their acute toxicity is due to the inhibition Florida International University, Herbert Wertheim College of Medicine, Department of Cellular Biology and Pharmacology, Miami, Florida 33199, USA georg.petroianu@fiu.edu 305-348-1474 305-348-1577 of the enzyme acetylcholinesterase (AChE), which inactivates the neurotransmitter acetylcholine (ACh) at cholinergic synapses. Esterase inhibition results from phosphylation (i.e. either phosphorylation or phosphonylation) of the serine hydroxyl group in the active center of the enzyme and translates into an "endogenous acetylcholine poisoning". The therapy of poisoning with organophosphorus compounds, which can be memorized by the acronym A FLOP = Atropine, FLuids, Oxygen, Pralidoxime [4] , is generally disappointing.
The history of the synthesis of organophosphorus compounds and of their applications has recently been investigated [5] [6] [7] . One therapeutic option is reactivation of phosphylated AChE by pyridinium oximes [8] . Working at Columbia in the laboratory of David Nachmansohn, Wilson and Ginsburg synthesized a number of pyridine oximes, one of which was pralidoxime, the first aldoxime cholinesterase reactivator of clinical relevance. In Great Britain, Davies and Green independently performed similar research [9] .
Pyridinium oximes reactivate phosphylated AChE by interacting with the anionic site of the enzyme. An optimal orientation of the reactivator at the catalytic site of the enzyme is facilitated by the pyridinium moiety, which thus increases efficacy [10, 11] . It is generally accepted that nerve gas exposure can be treated with oximes; however, the therapeutic value of oximes in human organophosphate pesticide poisoning is controversial [1, 12] .
One possible reason for the disappointing efficacy may be the generation of phosphylated oximes during AChE reactivation [12] [13] [14] . When interpreting kinetic studies of the reactivation and aging of organophosphate-AChE conjugates, physico-chemical properties of phosphylated oximes therefore need to be considered [15] . The octanolwater partition coefficient [logP], a concept introduced over a century ago by Berthelot (according to ref. [16] ) which is based on the partition of substances between oil and water, is often correlated with their biological activities [3, [17] [18] [19] . We have recently been able to demonstrate that phosphylation of two oximes in clinical use, pralidoxime and obidoxime, results in a significant reduction in the absolute value of logP, corresponding to an increase in lipophilicity [14] . K-27 is an experimental oxime with very promising in vivo and in vitro characteristics [20] [21] [22] [23] [24] [25] [26] [27] .
PURPOSE OF THE STUDY
To estimate logP values of phosphylated K-27 after "in-silico exposure" to a number of organophosphorus esters [ethyl-paraoxon, methyl-paraoxon, diisopropyl-fluoro-phosphate (DFP), VX, soman, tabun, sarin, cyclosarin], to compare them with the logP of the native oxime and with those of phosphylated pralidoxime and obidoxime and to discuss possible therapeutic relevance.
MATERIAL & METHOD
Chemical structures of all compounds were drawn using ChemDraw Ultra 12.0 (CambridgeSoft Software, PerkinElmer Inc. Waltham, Massachusetts). LogP values of organophosphorus esters, K-27 and phosphylated K-27 were estimated using the PrologP module of the Pallas 3413 software (CompuDrug Inc., Sedona, AZ, USA). Details of the algorithm used for calculations are given by [28] . The program takes into account all lipophilic and hydrophilic fragments of a specific compound and makes minor corrections based on octanol-water partition data, as available from the literature. The authors emphasize that their neural network-based method (pseudo-linear algorithms) combines the precision of non-linear approaches with the transparency of the early linear methods. The logP value of a substance is most relevant for neutral substances and is also useful as a general reference point to help compare overall hydrophobicity trends of compounds. 
RESULTS

DISCUSSION
Although the action mechanism of oximes is relatively well characterized in theory, their practical value remains uncertain and oximes have disappointed clinically [1, 29] . Due to the presence of a positively charged nitrogen atom, oxime molecules are polar, have a negative logP and are hydrophilic. Since only small lipophilic compounds easily penetrate the blood brain barrier, oximes barely enter the brain [30] . The brain concentration of the monopyridinium aldoxime pralidoxime is only 10% of its blood concentration, and penetration of bis-pyridinium aldoximes, such as obidoxime and K-27 is even lower [31, 32] .
The relationship between oxime efficacy and their entry into the brain is still a contentious issue. Is the restricted brain penetration of oximes the reason for their limited efficacy? Could superior efficacy be achieved by an increase in brain penetration? Apparently, the initial answer to these questions has been "yes", as demonstrated by the attempt to develop a less hydrophilic prodrug of pralidoxime [33] . This dihydropyridine derivative of pralidoxime, pro-2-PAM, was supposed to enter the brain more easily, and 2-PAM brain levels were indeed considerably higher when using this brain penetrating pro-drug. However, overall results were disappointing [34] , leading to the following conclusion in a recent review: "Increasing the BBB penetration by oximes does not actually lead to significant benefits of survival rate, but certainly amplifies the neurotoxic risks" [35] .
After correlating the in vivo toxicity of various oximes with different in vitro parameters [3, 19] , our own experimental studies indicate that a very negative logP (strong hydrophilicity) is a good predictor for low oxime toxicity (as assessed by survival). In addition, oximes with very negative logP (strong hydrophilicity) were significantly more efficacious in reducing DFP-induced mortality than more lipophilic ones. This suggests that limited brain penetration is actually desirable. One possible explanation for this unexpected conclusion is the formation of phosphylated oximes, which are generated by the reaction of oximes with organophosphorus-inhibited enzymes and which are highly toxic [13] . Phosphylation is the umbrella term used to describe phosphorylation (occurring during the reactivation of an enzyme inhibited by an organophosphate insecticide, such as paraoxon) or phosphonilation (occurring during the reactivation of an enzyme inhibited by an organophosphonate "nerve gas"). Organophosphates do not contain a direct phosphorus-carbon link, while organophosphonates do contain one. Phosphylated oximes are themselves potent inhibitors of AChE, sometimes much more potent than the initial offending organophosphate or organophosphonate, which generally translates into very high toxicity.
LogP: Pyridinium oximes are hydrophilic compounds (large negative value of logP) with very limited CNS penetration [30] [31] [32] . We have previously been able to demonstrate that phosphylation of two established oximes, obidoxime and pralidoxime, results in a significant decrease in the absolute logP value, corresponding to a reduction in hydrophilicity, i.e. an increase in lipophilicity [14] . This decrease in hydrophilicity favors penetration into the brain, where phosphylated oximes might phosphylate AChE, thereby defeating their therapeutic purpose and resulting in limited efficacy. In the case of K-27, the present study demonstrates that phosphylation by the majority of toxic organophosphates and -phosphonates increases hydrophilicity. Phosphylated K-27 therefore barely enter the brain. Our own animal work indicates that K-27 is much more efficacious than obidoxime or pralidoxime, when given in the same equitoxic dosage [23, 25, 26] . This superior efficacy may be related to the limited passage of phosphylated K-27 into the brain.
CONCLUSION
We conclude that an "ideal" oxime must not only be non-toxic itself, but should also yield non-toxic products after phosphylation. Moreover, these phosphylation products should ideally be very hydrophilic, thus barely entering the brain. K-27 might come closer to this ideal than the established oximes.
